Meta-analysis: Metformin Treatment in Persons at Risk for Diabetes Mellitus

Metformin treatment in persons at risk for diabetes improves weight, lipid profiles, and insulin resistance, and reduces new-onset diabetes by 40%. The long-term effect on morbidity and mortality should be assessed in future trials.